نتایج جستجو برای: budesonide

تعداد نتایج: 2228  

Journal: :Drugs 2008
Donald P Tashkin Stephen I Rennard Paula Martin Sulabha Ramachandran Ubaldo J Martin Philip E Silkoff Mitchell Goldman

BACKGROUND The combination of an inhaled corticosteroid (ICS) and a long-acting bronchodilator is recommended in the treatment of patients with chronic obstructive pulmonary disease (COPD) who have frequent exacerbations. Budesonide/formoterol dry powder inhaler (DPI) has demonstrated efficacy and tolerability in patients with COPD. OBJECTIVE To evaluate the efficacy and tolerability of budes...

Journal: :Gut 1994
N Cui D R Friend R N Fedorak

Although oral glucocorticoids are the treatment of choice for moderate to severe ulcerative pancolitis, their systemic side effects and adrenal suppression account for considerable morbidity. An oral glucocorticoid-conjugate (prodrug), budesonide-beta-D-glucuronide, which is not absorbed in the small intestine but is hydrolysed by colonic bacterial and mucosal beta-glucuronidase to release free...

Journal: :Thorax 2003
D B Price D Hernandez P Magyar J Fiterman K M Beeh I G James S Konstantopoulos R Rojas J A van Noord M Pons L Gilles J A Leff

BACKGROUND Inhaled corticosteroids (ICS) affect many inflammatory pathways in asthma but have little impact on cysteinyl leukotrienes. This may partly explain persistent airway inflammation during chronic ICS treatment and failure to achieve adequate asthma control in some patients. This double blind, randomised, parallel group, non-inferiority, multicentre 16 week study compared the clinical b...

Journal: :The European respiratory journal 2003
W Szafranski A Cukier A Ramirez G Menga R Sansores S Nahabedian S Peterson H Olsson

The efficacy and safety of budesonide/formoterol in a single inhaler compared with placebo, budesonide and formoterol were evaluated in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). In a 12-month, randomised, double-blind, placebo-controlled, parallel-group study in 812 adults (mean age 64 yrs, mean forced expiratory volume in one second (FEV1) 36% predicted nor...

Journal: :Annals of the rheumatic diseases 2004
J R Kirwan R Hällgren H Mielants F Wollheim E Bjorck T Persson C Book S Bowman M Byron N Cox M Field L Kanerud M Leirisalo-Repo M Malaise A Mohammad R Palmer I F Petersson B Ringertz P Sheldon M Simonsson N Snowden F Van den Bosch

OBJECTIVES To compare budesonide, a locally acting glucocorticoid with minimal systemic exposure, with conventional glucocorticoid treatment and placebo in rheumatoid arthritis. METHODS A double blind, randomised, controlled trial over 12 weeks in 143 patients with active rheumatoid arthritis, comparing budesonide 3 mg daily, budesonide 9 mg daily, prednisolone 7.5 mg daily, and placebo. Part...

Journal: :Acta poloniae pharmaceutica 2016
Paweł Kaliszewski Danuta Kończak Piotr Chołbiński Mariola Wicka Dorota Michalak Dorota Kwiatkowska Sylwia Lewandowska-Pachecka Jacek Namieśnik Andrzej Pokrywka

According to the World Anti-Doping Agency (WADA) Prohibited List, glucocorticosteroids are prohibited in competition and only when administered by oral, intravenous, intramuscular or rectal routes. Up to now, in order to differentiate whether glucocorticosteroids were administered by one of the prohibited routes or not, a specific reporting limit for urinary concentrations of parent compounds a...

2014
Hany SM Ali Peter York Amir Amani Nicholas Blagden

This study aimed to determine the aerosolization behavior of a nanodispersion of budesonide, prepared using microfluidic reactors. The size and morphology of budesonide nanoparticles were characterized by photon correlation spectroscopy (PCS) and transmission electron microscopy (TEM). Processing/formulation parameters for formation of the nanoparticles were studied to determine their effects o...

Journal: :The New England journal of medicine 2000
L Agertoft S E Pedersen

INTRODUCTION Short-term studies have shown that inhaled corticosteroids may retard the growth of children with asthma. The effect of long-term treatment on adult height is, however, uncertain. MATERIAL AND METHODS We conducted a prospective study of children with asthma to examine the effect of long-term treatment with inhaled budesonide on adult height. We report on 211 children who have att...

2008
M Turpeinen K Nikander A S Pelkonen P Syvänen R Sorva H Raitio P Malmberg K Juntunen-Backman T Haahtela

OBJECTIVE To compare the effect of inhaled budesonide given daily or as-needed on mild persistent childhood asthma. Patients, design and INTERVENTIONS 176 children aged 5-10 years with newly detected asthma were randomly assigned to three treatment groups: (1) continuous budesonide (400 microg twice daily for 1 month, 200 microg twice daily for months 2-6, 100 microg twice daily for months 7-...

2017
David B Price Eran Gefen Gokul Gopalan Cristiana Miglio Rosie McDonald Vicky Thomas Simon Wan Yau Ming

OBJECTIVE The objective of this study was to determine whether the effectiveness of budesonide comparator is non-inferior to budesonide reference in the prevention of asthma exacerbations. Asthma-related hospitalizations and safety were also examined. METHODS This study used a matched, historic cohort design. Data were drawn from the Clinformatics™ Data Mart US claims database and included a ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید